VSEE
VSEE HEALTH, INC.
$0.1240
+0.81%
$6.0M
No data for this timeframe.
Vol
Market Cap$6.0M
Cap SizeNano Cap
Inst. Holders4 funds
Inst. Value$60.8K
Inst. Activity1 buys / 1 sells
Reddit Sentiment50° Neutral
SEC Reports1
Recent Activity
Jun 11, 2026
SEC
VSee Health entered into a Standby Equity Purchase Agreement (SEPA) with YA II PN, Ltd. for up to $10M in common stock s
8-K — Impact 7/10
May 31, 2026
Insider
CHEN MILTON disposed of 2,870,069 shares
Co-Chief Executive Officer
Apr 14, 2026
short_volume
Short Volume: VSEE — 61.2% short (0.3M / 0.5M)
Short: 329,285 | Exempt: 0 | TRF Vol: 538,053 | Short Ratio: 61.2% | Off-exchange volume (dark pool
Mar 23, 2026
Insider
Leonard Jerry was granted 66,845 shares
Chief Financial Officer @ $0.3700 ($24.7K)
Mar 23, 2026
Insider
Aisiku Imoigele was granted 128,342 shares
Co-Chief Executive Officer @ $0.3700 ($47.5K)
Inst.
UBS Group AG — NEAR_EXIT
1,463 shares ($892.00)
Inst.
BANK OF AMERICA CORP — ADD
78 shares ($48.00)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 24, 2025 | Maxim Group | INITIATE | Buy |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $53.4K | — |
| STATE STREET CORP | $4.7K | — |
| CWM, LLC | $2.1K | — |
| VANGUARD FIDUCIARY TRUST CO | $543.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 31, 2026 | CHEN MILTON | J | $0.00 |
| Mar 23, 2026 | Leonard Jerry | A | $24.7K |
| Mar 23, 2026 | Aisiku Imoigele | A | $47.5K |
| Mar 4, 2026 | FAIRFAX CYDONII | A | $15.0K |
| Mar 4, 2026 | WICKERSHAM DAVID | A | $15.0K |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
4 institutional holders with $60.8K total value (243,103 shares) as of 2026-Q1. Top holders: VANGUARD, STATE, CWM,.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 213,716 | $53.4K | 87.9% | — |
| 2 | STATE STREET CORP | 18,900 | $4.7K | 7.8% | — |
| 3 | CWM, LLC | 8,316 | $2.1K | 3.4% | — |
| 4 | VANGUARD FIDUCIARY TRUST CO | 2,171 | $543.00 | 0.9% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 52,509 | 1,463 | -97.2% | $892.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 55 | 78 | +41.8% | $48.00 | 2025-Q3 |
| UBS Group AG | TRIM | 90,150 | 52,509 | -41.8% | $60.9K | 2025-Q2 |
| UBS Group AG | ADD | 59,527 | 90,150 | +51.4% | $108.2K | 2025-Q1 |
| UBS Group AG | DOUBLED | 8,661 | 59,527 | +587.3% | $81.0K | 2024-Q4 |
8 unique insiders with 10 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 31, 2026 | CHEN MILTON | Co-Chief Executive Officer | J | 2,870,069 | — | — |
| Mar 23, 2026 | Leonard Jerry | Chief Financial Officer | AWARD | 66,845 | $0.3700 | $24.7K |
| Mar 23, 2026 | Aisiku Imoigele | Co-Chief Executive Officer | AWARD | 128,342 | $0.3700 | $47.5K |
| Mar 4, 2026 | FAIRFAX CYDONII V. | Director | AWARD | 40,107 | $0.3740 | $15.0K |
| Mar 4, 2026 | WICKERSHAM DAVID L. | Director | AWARD | 40,107 | $0.3740 | $15.0K |
| Mar 4, 2026 | O'SULLIVAN COLIN P. | Director | AWARD | 40,107 | $0.3740 | $15.0K |
| Mar 4, 2026 | METZGER SCOTT | Director | AWARD | 40,107 | $0.3740 | $15.0K |
| Mar 4, 2026 | LOWDERMILK KEVIN | Director | AWARD | 40,107 | $0.3740 | $15.0K |
| Feb 23, 2026 | WICKERSHAM DAVID L. | Director | CONVERT | 759,916 | $0.3200 | $243.2K |
| Feb 23, 2026 | WICKERSHAM DAVID L. | Director | CONVERT | 243,173.14 | — | — |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Feb 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 24, 2025 | Maxim Group | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Nov 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Oct 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Sep 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
4 mentions
0 bullish
0 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 27, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| May 27, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Apr 15, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 15, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
VSEE showing signs of a run
▲ 1
💬 0
⚡ 0.5
Apr 14, 2026
short_volume
Short Volume: VSEE — 61.2% short (0.3M / 0.5M)
Short: 329,285 | Exempt: 0 | TRF Vol: 538,053 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
Apr 8, 2026
short_volume
Short Volume: VSEE — 64.3% short (0.3M / 0.5M)
Short: 347,841 | Exempt: 500 | TRF Vol: 540,974 | Short Ratio: 64.3% | Off-exchange volume (dark pool + OTC)